Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Remix Therapeutics has raised $60.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Remix Therapeutics's investors include ARCH Venture Partners, Foresite Capital, The Column Group, Atlas Venture, Alexandria Venture Investments.
Remix Therapeutics is headquartered in Cambridge, United States.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Remix Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remix Therapeutics — Funding & Investors." VCBacked, January 3, 2024, https://www.vcbacked.co/company/remix-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Remix Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/remix-therapeutics
{{cite web |title=Remix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/remix-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated